Cargando…
Evolution of β-Cell Replacement Therapy in Diabetes Mellitus: Islet Cell Transplantation
Diabetes mellitus remains one of the leading causes of morbidity and mortality worldwide. According to the Centers for Disease Control and Prevention, approximately 23.6 million people in the United States are affected. Of these individuals, 5 to 10% have been diagnosed with Type 1 diabetes mellitus...
Autores principales: | Jahansouz, Cyrus, Jahansouz, Cameron, Kumer, Sean C., Brayman, Kenneth L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195999/ https://www.ncbi.nlm.nih.gov/pubmed/22013505 http://dx.doi.org/10.1155/2011/247959 |
Ejemplares similares
-
Islet Transplantation & β-Cell Replacement Therapies for Diabetes
por: Berney, Thierry, et al.
Publicado: (2011) -
Current Status of Immunomodulatory and Cellular Therapies in Preclinical
and Clinical Islet Transplantation
por: Chhabra, Preeti, et al.
Publicado: (2011) -
Single-donor islet transplantation in type 1 diabetes: patient selection and special considerations
por: Tatum, Jacob A, et al.
Publicado: (2017) -
Bariatric Surgery: A Perspective for Primary Care
por: Kizy, Scott, et al.
Publicado: (2017) -
B7-H4 Pathway in Islet Transplantation and β-Cell Replacement Therapies
por: Wang, Xiaojie, et al.
Publicado: (2011)